Emerging Therapies will explore the cutting-edge advancements and emerging therapies that are transforming the field of head and neck surgery. It will highlight groundbreaking research, innovative treatment strategies, and their impact on improving patient outcomes. Attendees will gain insights into the latest developments in targeted therapies, immunotherapy, and novel drug treatments, as well as their integration into clinical practice.
Track 25:1 Immunotherapy in Head and Neck Cancer
Track 25:2 Targeted Therapies and Precision Medicine
Track 25:3 Gene Therapy Approaches
Track 25:4 Combination Therapies
Track 25:5 Innovative Drug Developments
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
